Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-046150

Chief Executive Officer bought 444,444 shares at $0.90 ($400,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nolan Sean P. Chief Executive Officer 2023-08-16 Purchase +444,444 $0.90 $400,000 1,535,545 I
Open-market purchases · 444,444 sh · avg $0.90 · $400,000
Loading xslF345X05/doc4.xml…